3 Amendments of Georgios PAPASTAMKOS related to 2010/0208(COD)
Amendment 34 #
Proposal for a regulation – amending act
Recital 8
Recital 8
(8) According to the legal framework for the authorisation of GMOs, the level of protection of human/animal health and of the environment chosen in the EU cannot be revised by a Member State and this situation must not be altered. However Member States may adopt measures restricting or prohibiting the cultivation of all or particular GMOs in all or part of their territory on the basis of grounds relating to the public interest other than those already addressed by the harmonised set of EU rules which alreadycomplementary to or other than those which have already been the subject of an assessment pursuant to the harmonised EU rules. The reasons that may be cited by the Member States include complementary environmental effects other than those already covered by the risk assessment provided for procedures to take into account the risks that a GMO for cultivation may pose on health and the environmentin Part C of Directive 2001/18/EC, such as the evaluation of scientific data in relation to the environmental impact at national, regional or local level, or reasons related to risk management. These reasons may include agronomic justifications related to specific geographical features, the diversification of agricultural structures and the specific nature of farming practices, as well as socio-economic considerations such as the feasibility and cost of measures to ensure separation, prevent contamination and carry out checks on seeds, or to protect quality agricultural products (PDO and PGI, organic products), as well as consumer habits. Those measures should furthermore be in conformity with the Treaties, in particular as regards the principle of non discrimination between national and non national products and Articles 34 and 36 of the Treaty on the Functioning of the European Union, as well as with the relevant international obligations of the Union, notably in the context of the World Trade Organisation.
Amendment 43 #
Proposal for a regulation – amending act
Recital 9
Recital 9
(9) On the basis of the subsidiarity principle, the purpose of this Regulation is not to harmonize the conditions of cultivation in Member States but to grant freedom to Member States to invoke other grounds complementary to or other than scientific assessment of health and environmental risks to ban cultivation of GMOs on their territory. In addition one of the purposes of Directive 98/34/EC of the European Parliament and of the Council of 22 June 1998 laying down a procedure for the provision of information in the field of technical standards and regulations which is to allow the Commission to consider the adoption of binding acts at EU level would not be served by the systematic notification of Member States' measures under that Directive. Moreover, since measures which Member States can adopt under this Regulation cannot have as a subject the placing of the market of GMOs and thus does not modify the conditions of placing on the market of GMOs authorised under the existing legislation, the notification procedure under Directive 98/34/EC does not appear the most appropriate information channel for the Commission. Therefore, by derogation, Directive 98/34/EC should not be applicable. A simpler notification system of the national measures prior to their adoption appears to be a more proportionate tool for the Commission to be aware of these measures. Measures which Member States intend to adopt should thus be communicated together with their reasons to the Commission and to the other Member States one month prior to their adoption for information purposes.
Amendment 53 #
Proposal for a regulation – amending act
Article 1 - point 1
Article 1 - point 1
Directive 2001/18/EC
Article 26 b – paragraph 1 - point a
Article 26 b – paragraph 1 - point a
(a) those measures are based on: - grounds other than those related to the assessment of the adverse effect on health and environmental effect which might arise from the deliberate release or the placing on the market of GMOs, complementary to the environmental effects studied as part of the assessment of the adverse effects on the environment carried out pursuant to Part C of this Directive; or - other legitimate reasons which may include socio-economic effects, inter alia;